<i>In vitro</i> antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19
Carolina Q. Sacramento(National Institute of Science and Technology), Thiago Moreno L. Souza(National Institute of Science and Technology), Vinícius Cardoso Soares(Universidade Federal do Rio de Janeiro), Caroline S. de Freitas(Fundação Oswaldo Cruz), Carolina Pedrosa(D’Or Institute for Research and Education), Gabriela Vitória(D’Or Institute for Research and Education), Aitor Garzia(Rockefeller University), Steffen Jockusch(Bowling Green State University), Letícia R. Q. Souza(D’Or Institute for Research and Education), Felipe Saraiva, Xuanting Wang(China Pharmaceutical University), Aline de Paula Dias da Silva(Fundação Oswaldo Cruz), Tácio Vinício Amorim Fernandes(Instituto Nacional de Metrologia, Qualidade e Tecnologia), Thomas Tuschl(Howard Hughes Medical Institute), Stevens K. Rehen(Universidade Federal do Rio de Janeiro), Lucas Villas Bôas Hoelz(Fundação Oswaldo Cruz), Chuanjuan Tao(New York Genome Center), Mônica M. Bastos(Fundação Oswaldo Cruz), Patrı́cia T. Bozza(Fundação Oswaldo Cruz), Minchen Chien(New York Genome Center), Natalia Fintelman‐Rodrigues(Fundação Oswaldo Cruz), Andrew Owen(University of Liverpool), Wei Xie(Memorial Sloan Kettering Cancer Center), Marcelo Alves Ferreira, Fernando A. Bozza(D’Or Institute for Research and Education), Dinshaw J. Patel(Memorial Sloan Kettering Cancer Center), Suelen da Silva Gomes Dias(Fundação Oswaldo Cruz), Frederico Silva Castelo Branco(Fundação Oswaldo Cruz), Jingyue Ju(New York Genome Center), Rajith K. R. Rajoli(University of Liverpool), Carine dos Santos da Silva(Fundação Oswaldo Cruz), Jairo R. Temerozo(Fundação Oswaldo Cruz), Camila R. R. Pão(Fundação Oswaldo Cruz), Dumith Chequer Bou‐Habib(Fundação Oswaldo Cruz), Mayara Mattos(Fundação Oswaldo Cruz), André C. Ferreira(Fernando Pessoa University), James J. Russo(New York Genome Center), Núbia Boechat(Fundação Oswaldo Cruz), Marília Zaluar P. Guimarães(Universidade Federal do Rio de Janeiro), Livia Goto‐Silva(D’Or Institute for Research and Education)
Cited by 104
Related Papers
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
|Nature|2008|2.4k
A pancreatic islet-specific microRNA regulates insulin secretion
|Nature|2004|2.1k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Human telomere, oncogenic promoter and 5'-UTR G-quadruplexes: diverse higher order DNA and RNA targets for cancer therapeutics
|Nucleic Acids Research|2007|880